Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
about
How does Zika virus cause microcephaly?Transposon mutagenesis of the Zika virus genome highlights regions essential for RNA replication and restricted for immune evasion.ADE-ing and Abetting Zika.Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.Delineating antibody recognition against Zika virus during natural infectionZika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virusZika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future PerspectivesZika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.Macaque monkeys in Zika virus research: 1947-present.DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests.Impact of Zika virus for infertility specialists: current literature, guidelines, and resources.Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.Taking the Defensive: Immune Control of Zika Virus Infection.Antagonism of type I interferon by flaviviruses.A novel mechanism of antibody-mediated enhancement of flavivirus infection.A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.Zika virus infection confers protection against West Nile virus challenge in mice.Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not Alter the Production of Interleukin 6 in FcγRII-Expressing K562 Cells.Flavivirus cross-reactivity, Guillain-Barré syndrome, and hematopoietic stem cell transplant patient: Comment response.Non-human Hosts and Zika Virus Maintenance.Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model.Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens.Assessing the population at risk of Zika virus in Asia - is the emergency really over?Analysing increasing trends of Guillain-Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.T Cell Immunity to Zika and Dengue Viral Infections.Virus and Antibody Dynamics in Travelers With Acute Zika Virus Infection.Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction.Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.Development of Zika Virus Vaccines.Immune Response to Dengue and Zika.Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West Africa.
P2860
Q30145540-79DDB75C-CBD5-41B4-A9C7-D44781860B5CQ30145598-23C60906-13D1-4FCD-BD5E-00972DD76C83Q30145626-0C56EC73-F15B-4CD1-B782-9DA574E20B56Q30145645-06F0E6E9-4527-46BE-9B7B-2F6857730E7FQ30145646-95E85C23-0878-4F4F-AE72-65728931E9F9Q33798068-ECA1440A-6C18-46C4-98D5-1A2C577F7D8AQ33850577-CE1086DC-18B0-4CE2-89EC-A6686E47A1A4Q33911252-ED2DF6F3-40BF-492A-9FC6-00662EA56E97Q38156536-325CB5B5-18F1-4423-A7AA-74B667A31CF5Q38156667-A97F3768-B295-4681-820C-A7D400CB6C10Q38156674-4C07AEE3-1DD3-4097-8B84-ACD521A7183CQ38157306-2C2518C7-170A-4284-B46D-C9EABA728E6EQ38157397-F5C58085-7C89-44DA-9C5D-4CDA2CC802CDQ38157439-0FBF9543-94A9-40E3-A858-A783D242CF2DQ38158070-B927D4FD-1C8B-4AEF-9D20-F84592D4BA4CQ38158407-D6C9B490-2681-4F99-9C01-E5753B37E6D3Q38848948-1066EB9A-6384-4669-B2E6-ECF5406306C1Q39347222-D22D3ABF-AAB9-4BA6-AE22-ABCEB0FEE5F2Q40038769-AC4CEC2C-5F81-4CB6-9207-605416FEC5E7Q41596362-66F1BC81-5B20-4882-AD13-90DB806F32C3Q41918368-AAFD2333-1203-49A0-ACE5-AFDBC6E0E4C5Q41924121-1B980EE7-75A2-4A46-B6FB-6E5D4C2123A1Q41995967-1C70F835-33C4-4ABE-9C56-05026FEDD0B6Q43038325-615D5010-7DB9-46C6-9B3B-BA4D9AE3138CQ43038878-F25F6882-83BC-47E6-BAB6-D3AF97FCF3C5Q43046666-0670653E-0E62-4B1D-AA20-99A521A17F31Q43046676-00B6EC04-85F8-4E56-A216-E03B820ADCF8Q43046770-E89D63AC-8962-4792-AD23-ABA17D83AAE8Q43047028-C2BCFA52-034D-45DE-8EC5-A2C8020C449EQ44843450-58C183A8-306B-49DC-BEE4-A6571C587208Q45324313-94AF6347-054F-4772-8998-BC94C27C1115Q45324929-7FABF831-4BA8-4126-ADA0-FF4E5F2E116BQ46518619-DCE23F85-18B7-4804-A3E0-BACCD3313E98Q47232695-0C2C7210-1BD6-4541-B02C-67E740533A31Q47315490-867F42E1-EB33-457A-9E38-7E48D2807224Q47548142-304269D7-6A07-4B92-AEFB-974A36202B14Q47550067-EC6FA33F-01F3-47BA-AF95-05A82DE712F2Q47551875-FDE50A1E-0D21-49F6-95F0-795419AD8A43Q47551925-FC520FE7-9F53-4499-94D0-D28EB64D3F55Q47555900-B8ECF9F3-D06F-4F2C-9C3A-0133D38599A8
P2860
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@ast
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@en
type
label
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@ast
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@en
prefLabel
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@ast
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@en
P2093
P2860
P50
P356
P1433
P1476
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
@en
P2093
Gregory A Foster
Julia A Brown
Susan L Stramer
P2860
P304
P356
10.1126/SCIENCE.AAL4365
P407
P50
P577
2017-03-30T00:00:00Z